Bavarian Nordic’s MVA-BN vaccine, has become the first mpox vaccine to be added to the World Health Organization (WHO) prequalification (PQ) list, enabling its use globally.

The WHO has also recommended that single doses be given in supply-constrained outbreak situations instead of the usual two doses, and “off label” use for children as the vaccine is not yet approved for under-18s.

https://healthpolicy-watch.news/who-pre-qualifies-first-mpox-vaccine-recommends-single-dose-and-off-label-use-for-children/